3.1 Clinical cure at 24 to 28 days (ITT) |
1 |
673 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.76 [0.55, 1.05] |
3.1.1 Children |
1 |
673 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.76 [0.55, 1.05] |
3.2 Clinical cure at 24 to 28 days (bacteriological per protocol population) |
1 |
482 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.29 [0.11, 0.73] |
3.2.1 Children |
1 |
482 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.29 [0.11, 0.73] |
3.3 Relapse on day 38 to 45 (ITT) |
1 |
673 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.55, 1.02] |
3.3.1 Children |
1 |
673 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.55, 1.02] |
3.4 Relapse on day 38 to 45 (bacteriological per protocol) |
1 |
422 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.88 [0.43, 1.82] |
3.4.1 Children |
1 |
422 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.88 [0.43, 1.82] |
3.5 Adverse events (all participants) |
1 |
673 |
Odds Ratio (M‐H, Fixed, 95% CI) |
2.67 [1.78, 3.99] |
3.5.1 Children |
1 |
673 |
Odds Ratio (M‐H, Fixed, 95% CI) |
2.67 [1.78, 3.99] |